HomeNews & MediaPress ReleasesPhilogen announces authorization from FDA of a pivotal registration trial in USA for the treatment of resectable melanomaPress ReleasePublishedOctober 12, 2017Philogen announces authorization from FDA of a pivotal registration trial in USA for the treatment of resectable melanomaPhilogen announces authorization from FDA of a pivotal registration trial in USA
